ATROPINE and CARDIAC ARREST

Overview

CARDIAC ARREST is the #12 most commonly reported adverse reaction for ATROPINE, manufactured by Meridian Medical Technologies LLC. There are 308 FDA adverse event reports linking ATROPINE to CARDIAC ARREST. This represents approximately 1.9% of all 16,519 adverse event reports for this drug.

Patients taking ATROPINE who experience cardiac arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC ARREST is a less commonly reported adverse event for ATROPINE, but still significant enough to appear in the safety profile.

Other Side Effects of ATROPINE

In addition to cardiac arrest, the following adverse reactions have been reported for ATROPINE:

• DRUG INEFFECTIVE — 610 reports
• OFF LABEL USE — 555 reports
• DIARRHOEA — 535 reports
• HYPOTENSION — 487 reports
• NAUSEA — 457 reports
• DEATH — 446 reports
• DYSPNOEA — 395 reports
• FATIGUE — 383 reports
• BRADYCARDIA — 380 reports
• VOMITING — 363 reports

Other Drugs Associated with CARDIAC ARREST

The following drugs have also been linked to cardiac arrest in FDA adverse event reports:

Does ATROPINE cause CARDIAC ARREST?

CARDIAC ARREST has been reported as an adverse event in 308 FDA reports for ATROPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC ARREST with ATROPINE?

CARDIAC ARREST accounts for approximately 1.9% of all adverse event reports for ATROPINE, making it a notable side effect.

What should I do if I experience CARDIAC ARREST while taking ATROPINE?

If you experience cardiac arrest while taking ATROPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages